Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014

[GlobeNewswire] – NEW YORK — Tonix Pharmaceuticals Holding Corp. , a development stage specialty pharmaceutical company, today announced that it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. … more

View todays social media effects on TNXP

View the latest stocks trending across Twitter. Click to view dashboard

See who Tonix is hiring next, click here to view